Clinical Pearls & Common Scenarios

  • FENa < 1%: Prerenal AKI (not reliable if diuretics used)
  • FEUrea < 35%: Better for patients on diuretics
  • BUN:Cr > 20: Suggests prerenal state
  • FENa can be <1% also in contrast nephropathy, myoglobinuria, acute GN

  • Spot urine PCR (protein:creatinine) ≥ 0.3 g/g: Significant proteinuria
  • ≥ 3.5 g/day: Nephrotic range
  • Microalbuminuria (30–300 mg/day): Early diabetic nephropathy
  • ACE-i/ARBs reduce proteinuria independently of blood pressure lowering

  • ↑ Cr ≥ 0.3 mg/dL in 48h, OR
  • ↑ Cr ≥ 1.5. baseline within 7 days, OR
  • UO < 0.5 mL/kg/hr for ≥ 6 hours

  • Muddy brown casts: ATN (ischemic or nephrotoxic
  • RBC casts: Glomerulonephritis (pathognomonic)
  • WBC casts: AIN or pyelonephritis
  • Granular casts: Non-specific; ATN, CKD

  • Avoid: NSAIDs, metformin (eGFR <30), gadolinium (NSF risk), SGLT2i (ineffective <25 mL/min)
  • Reduce: Renally-cleared antibiotics (aminoglycosides, vancomycin, beta-lactams, gabapentin)
  • Contrast: Hold with eGFR <30 or AKI; ensure adequate hydration pre/post procedure
  • Digoxin toxicity risk ↑ with ↓ GFR (narrow therapeutic window)

  • CKD is an independent CV risk factor; mortality from CV disease exceeds ESRD
  • BP target: <130/80 mmHg (KDIGO 2021); ACE-i/ARB first-line if proteinuria present
  • SGLT2 inhibitors: Proven cardiorenal protection in CKD (CREDENCE, DAPA-CKD trials)
  • Anemia: Target Hgb 10–11.5 g/dL with ESA therapy; replete iron concurrently

Return back to the home page, click back or image above

Test your knowledge with the Bean Bowl on the Equilibrium Architects home page. A cumulation of board style questions from all sections.